Guide

Is Compounded Semaglutide Safe in 2026? What the Record Actually Shows

The honest answer is that safety depends on the pharmacy, and most providers will not name theirs. The FDA has flagged salt forms as not appropriate for compounding, issu

What have the FDA actions actually covered?

Read that carefully in both directions. The overwhelming majority of enforcement here concerns advertising, not what is in the vial. That is a genuine limit on how much the warning-letter count tells you about product safety.

It also cuts the other way: the FDA samples rather than reviewing every operator, so an absence of findings is weak evidence of anything.

Which FDA concern is about the product rather than the marketing?

Salt forms. Its sodium and acetate salts are not the same active ingredient as the base form in Wegovy and Ozempic. The FDA has said they are not appropriate for compounding. A salt form has not been through the review the base went through, and a provider using one is dispensing a different chemical entity from the one in the trials.

This is the single most useful safety question you can ask, it takes thirty seconds, and it applies to no other GLP-1.

How do I check a provider myself?

1. Name the pharmacy. Then look it up on the state board licensee database. Free, public, about ninety seconds. If the provider will not name it, the check ends there and so should your consideration.
2. 503A or 503B? Thirty seconds. It decides your exposure to the live bulks proposal.
3. Search the FDA warning-letter database for the brand and the parent company. Telehealth brands often trade under a different legal entity, and searching only the brand produces a false clear.
4. Ask the salt form and concentration in writing.
5. Ask what is refunded if supply is interrupted. The bulks proposal is unresolved and almost nobody addresses this.
6. Ask who reviews your intake and how fast they reply. A stated response time is something you can hold a provider to.

How does every provider score on the six tests?

Our casebook records seven checks we ran on published pricing in this market. Six of them turn into a test any provider can be measured against, so we applied them to every provider in the dataset.

What can no comparison site verify?

Whether a specific vial contains what its label says. Whether sterility practice met USP <797> on the day your batch was compounded. Whether the prescriber read your intake.

No comparison site can establish those from a desk. What we can do is record which providers answer the six questions above — and one of thirty answers all of them.

Frequently asked questions